These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23001318)

  • 1. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
    Coorevits L; Baert FJ; Vanpoucke HJ
    Clin Chem Lab Med; 2013 Apr; 51(4):825-31. PubMed ID: 23001318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Quantum Blue® rapid test for faecal calprotectin.
    Wassell J; Wallage M; Brewer E
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):55-8. PubMed ID: 21930735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
    Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ; Sydora BC; Fedorak RN
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
    Delefortrie Q; Schatt P; Grimmelprez A; Gohy P; Deltour D; Collard G; Vankerkhoven P
    Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin.
    Dolci A; Panteghini M
    Clin Chim Acta; 2012 Jan; 413(1-2):350-1. PubMed ID: 21982915
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
    Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
    Noebauer B; Ramic L; Konstantin A; Zachbauer C; Einwallner E
    Biochem Med (Zagreb); 2017 Oct; 27(3):030710. PubMed ID: 29180918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Two Calprotectin Rapid Tests in Daily Routine.
    Schulz C; Wex T; Arnim UV; Malfertheiner P
    Clin Lab; 2016 Jul; 62(7):1249-1254. PubMed ID: 28164652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
    Kristensen V; Lauritzen T; Jelsness-JØrgensen LP; Moum B
    Scand J Clin Lab Invest; 2015 Sep; 75(5):355-61. PubMed ID: 25856663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
    Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
    J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.